Qilin Feng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Qilin Feng

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Journal of Biomedical Science|January 19, 2025

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axisXuejie Gao, Qilin Feng, Qikai Zhang, et al.

Journal of Translational Medicine|November 28, 2023

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathwayYingcong Wang, Sanfeng Dong, Ke Hu, et al.

Leukemia|May 8, 2023

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myelomaLi Xu, Yingcong Wang, Guanli Wang, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Journal of Biomedical Science|January 19, 2025

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axisXuejie Gao, Qilin Feng, Qikai Zhang, et al.

Journal of Translational Medicine|November 28, 2023

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathwayYingcong Wang, Sanfeng Dong, Ke Hu, et al.

Leukemia|May 8, 2023

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myelomaLi Xu, Yingcong Wang, Guanli Wang, et al.

Pageof 5